	US 11,806,534 B2
	Systems and methods for stimulation-related biological circuit element analysis and use
Stephen Carcieri, Los Angeles, CA (US); G. Karl Steinke, Valencia, CA (US); Peter J. Yoo, Burbank, CA (US); Richard Mustakos, Simi Valley, CA (US); and Hemant Bokil, Santa Monica, CA (US)
Assigned to Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed by Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed on Feb. 19, 2019, as Appl. No. 16/279,764.
Application 16/279,764 is a division of application No. 14/813,734, filed on Jul. 30, 2015, granted, now 10,265,528.
Claims priority of provisional application 62/030,655, filed on Jul. 30, 2014.
Prior Publication US 2019/0184174 A1, Jun. 20, 2019
Int. Cl. A61N 1/36 (2006.01); A61N 1/372 (2006.01); G16H 50/50 (2018.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01); A61N 1/05 (2006.01)

CPC A61N 1/36128 (2013.01) [A61N 1/36185 (2013.01); A61N 1/37247 (2013.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01); A61N 1/0534 (2013.01); A61N 1/0551 (2013.01)]

20 Claims

1. A method for electrical stimulation, comprising:

grouping, into a plurality of groups, volumes of activation (VOAs) associated with stimulations of a patient population according to clinical effects;

for at least one of the groups, identifying a biological circuit element over which a threshold number of the VOAs overlie and produce a therapeutic effect;

receiving a target stimulation site associated with a biological circuit containing the biological circuit element, wherein the target stimulation site is different from a site of an implanted lead; and

based on the identification of the biological circuit element, identifying and outputting stimulation programming parameters to stimulate the target stimulation site from the site of the implanted lead along the biologic circuit containing the biological circuit element.